Related references
Note: Only part of the references are listed.Characterization of Inhibitor-Bound α-Synuclein Dimer: Role of α-Synuclein N-Terminal Region in Dimerization and Inhibitor Binding
Yoshiki Yamaguchi et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Low Dosage of Rasagiline and Epigallocatechin Gallate Synergistically Restored the Nigrostriatal Axis in MPTP-Induced Parkinsonism
Lydia Reznichenko et al.
NEURODEGENERATIVE DISEASES (2010)
Pathophysiology of Huntingtonʼs disease: from huntingtin functions to potential treatments
Emmanuel Roze et al.
CURRENT OPINION IN NEUROLOGY (2009)
Inhibition of α-synuclein fibril assembly by small molecules: Analysis using epitope-specific antibodies
Masami Masuda et al.
FEBS LETTERS (2009)
Effect of grape seed extract on blood pressure in subjects with the metabolic syndrome
Brahmesh Sivaprakasapillai et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
Consumption of Grape Seed Extract Prevents Amyloid-beta Deposition and Attenuates Inflammation in Brain of an Alzheimer's Disease Mouse
Yan-Jiang Wang et al.
NEUROTOXICITY RESEARCH (2009)
Amyotrophic lateral sclerosis
Lokesh C. Wijesekera et al.
ORPHANET JOURNAL OF RARE DISEASES (2009)
Green tea epigallocatechin-3-gallate (EGCG) reduces β-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice
Kavon Rezai-Zadeh et al.
BRAIN RESEARCH (2008)
Intracellular degradation of misfolded proteins in polyglutamine neurodegenerative diseases
Xiang Li et al.
BRAIN RESEARCH REVIEWS (2008)
Simultaneous Manipulation of Multiple Brain Targets by Green Tea Catechins: A Potential Neuroprotective Strategy for Alzheimer and Parkinson Diseases
Silvia A. Mandel et al.
CNS NEUROSCIENCE & THERAPEUTICS (2008)
Protein Folding and Misfolding on Surfaces
Massimo Stefani
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2008)
Immunological features of alpha-synuclein in Parkinson's disease
Cintia Roodveldt et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Grape-derived polyphenolics prevent Aβ oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease
Jun Wang et al.
JOURNAL OF NEUROSCIENCE (2008)
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Dagmar E. Ehrnhoefer et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation
Alex Crowe et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Phosphorylation and cleavage of tau in non-AD tauopathies
Angela L. Guillozet-Bongaarts et al.
ACTA NEUROPATHOLOGICA (2007)
Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies
Mari Yoshida
NEUROPATHOLOGY (2006)
Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models
Dagmar E. Ehrnhoefer et al.
HUMAN MOLECULAR GENETICS (2006)
Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for α-synuclein fibrils in vitro
K Ono et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1/2 protects against mutant huntingtin-associated toxicity
BL Apostol et al.
HUMAN MOLECULAR GENETICS (2006)
Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice
K Rezai-Zadeh et al.
JOURNAL OF NEUROSCIENCE (2005)
Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins
S Taniguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells
M Pickhardt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Potential structure/function relationships of predicted secondary structural elements of tau
TC Gamblin
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
MARKing tau for tangles and toxicity
G Drewes
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Prefibrillar amyloid protein aggregates share common features of cytotoxicity
M Bucciantini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The formation of straight and twisted filaments from short tau peptides
WJ Goux et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The flavonoid baicalein inhibits fibrillation of α-synuclein and disaggregates existing fibrils
M Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro:: implications for the prevention and therapeutics of Alzheimer's disease
K Ono et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-β structure
J Berriman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
α-synuclein aggregation:: A link between mitochondrial defects and Parkinson's disease?
SJ Lee
ANTIOXIDANTS & REDOX SIGNALING (2003)
Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments
S Barghorn et al.
BIOCHEMISTRY (2002)
Subchronic 3-month oral toxicity study of grape seed and grape skin extracts
SS Bentivegna et al.
FOOD AND CHEMICAL TOXICOLOGY (2002)
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
J Lewis et al.
SCIENCE (2001)
Neurodegenerative tauopathies
VMY Lee et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
L Buée et al.
BRAIN RESEARCH REVIEWS (2000)
Share Paper
